文献速递腹部介入US

肝活检针芯尺寸对标本合格性与操作并发症影响的前瞻性研究

Prospective Study of the Impact of Liver Biopsy Core Size on Specimen Adequacy and Procedural Complications.
PubMed 文献 · AJR Am J Roentgenol · 2017-11-01

150例转诊行肝活检患者随机接受16G或18G超声引导下针芯活检,两组均无显著出血且疼痛评分无差异;16G标本平均长度短于18G(1.7 cm vs 1.9 cm,P=0.03),但门管区数目更多(14 vs 13,P=0.03);按AASLD标准,16G标本合格率85%、18G为80%,差异无统计学意义。

要点

  • 16G与18G超声引导肝活检安全性相似,均无显著出血且疼痛评分无差异。
  • 16G标本虽更短(1.7 cm vs 1.9 cm),但门管区数目更多(14 vs 13)。
  • 按AASLD标准,16G与18G标本合格率分别为85%和80%,差异无统计学意义。

核心结论

  • 超声引导下18G与16G针芯活检安全性相似;应用AASLD质量控制合格阈值时,18G或16G标本中很大比例不合格,标本合格性不受活检针规显著影响。

研究设计与样本

  • 前瞻性随机研究,150例转诊行肝活检患者随机接受16G或18G超声引导下针芯活检,以AASLD指南定义的11个及以上门管区为标本合格标准,采用卡方检验和线性回归模型分析病理指标与疼痛评分差异。

关键影像表现/征象

  • 两组均无显著出血发生,活检后疼痛评分无差异。
  • 16G针获取的标本平均长度短于18G针(1.7 cm vs 1.9 cm,P=0.03)。
  • 16G活检获取的门管区平均数目多于18G系统(14 vs 13,P=0.03)。

诊断标准与关键数值

  • 依据AASLD指南,标本合格定义为门管区数目≥11个。
  • 16G活检标本合格率85%,18G活检标本合格率80%,差异无统计学意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: An American Association for the Study of Liver Diseases (AASLD) consensus document stressed the importance of obtaining sufficient liver biopsy specimens to minimize sampling errors. Many centers continue to use smaller-diameter core systems to minimize perceived complication risks. The objective of this study was to assess the impact of core gauge (18- vs 16-gauge) on specimen adequacy and procedural complications.

SUBJECTS AND METHODS: One hundred fifty patients referred for liver biopsy were randomized to undergo 16- or 18-gauge ultrasound (US)-guided core biopsy. Hemorrhage was qualitatively evaluated, and pain was assessed using a 10-point rating scale. The length and number of portal tracts per specimen were assessed. On the basis of the AASLD guidelines, specimen adequacy was defined as 11 or more portal tracts. Differences in pathology metrics and pain scoring were assessed using chi-square and linear regression models.

RESULTS: No significant hemorrhage occurred in either group, and there was no difference in postbiopsy pain scores. The mean specimen length obtained with 16-gauge needles was less than that obtained with 18-gauge needles (1.7 vs 1.9 cm, p = 0.03). The mean number of portal tracts obtained with 16-gauge biopsies was greater than obtained with 18-gauge systems (14 vs 13, p = 0.03); 85% of 16-gauge biopsy specimens and 80% of 18-gauge biopsy specimens were adequate on the basis of the AASLD criteria, although this difference was not statistically significant.

CONCLUSION: US-guided 18- and 16-gauge core biopsies are similarly safe. A large percentage of 18- or 16-gauge specimens are inadequate when AASLD quality control adequacy thresholds are applied, and specimen adequacy is not significantly affected by biopsy gauge.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Tublin ME, Blair R, Martin J, et al. Prospective Study of the Impact of Liver Biopsy Core Size on Specimen Adequacy and Procedural Complications. AJR Am J Roentgenol. 2017. PMID: 29091001. doi:10.2214/AJR.17.17792

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。